Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 06:05 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Corneal Versus Conjunctival Delivery Using a Delivery Device
NCT00143429 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · PHASE2 · withdrawn · last registry update 2021-02-02 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PTGFR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-01-19Results posted on the registry: Aerie Pharmaceuticals, Netarsudil/Latanoprost 0.02%/0.005% + GANFORT® (NCT03284853)
- 2021-12-21Phase 3 first posted: TearClear Corp, Latanoprost ophthalmic solution, 0.005% + TC-002 latanoprost ophthalmic solution, 0.005% (NCT05165290)
- 2021-11-19Also stopped (withdrawn): Sun Pharmaceutical Industries Limited, SDP-133 + Lumigan (NCT03927443)
- 2021-10-11Results posted on the registry: Ocular Therapeutix, Inc., Travoprost (NCT02914509)
- 2021-08-23Results posted on the registry: Icahn School of Medicine at Mount Sinai, Latanoprost 0.005% + Latanoprost bunod 0.024% (NCT03949244)
- 2021-07-28Results posted on the registry: Allergan, Bimatoprost SR + Active Comparator: Timolol 0.5% (NCT02250651)
- 2021-06-21Also stopped (withdrawn): West Virginia University, Latanoprost ophthalmic solution + Timolol ophthalmic solution (NCT03648229)
- 2021-05-24Phase 3 first posted: Laboratoires Thea, Bimatoprost Timolol (T4030) + Bimatoprost Timolol (Ganfort) (NCT04898387)
- 2021-05-18Phase 3 first posted: Mankind Pharma Limited, Test - Bimatoprost 0.01% Ophthalmic Solution + Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution) (NCT04890106)
- 2021-05-03Results posted on the registry: Pfizer, PF-04217329 + latanoprost vehicle (NCT00934089)
- 2021-04-30Results posted on the registry: Pfizer, PF-04217329 - Lowest Dose + PF-04217329 - Low Dose (NCT00572455)
- 2021-03-05Results posted on the registry: Tulane University, bimatoprost 0.03% ophthalmic solution (NCT02830776)
- 2021-02-02Also stopped (withdrawn): Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Xalatan (NCT00283764)
- 2020-12-01Results posted on the registry: Université de Sherbrooke, Brand name travoprost + Generic travoprost (NCT02796560)
- 2020-11-16Phase 3 first posted: Nicox Ophthalmics, Inc., NCX 470 0.1% + Latanoprost 0.005% (NCT04630808)
- 2020-11-16Results posted on the registry: Peregrine Ophthalmic, POLAT-001 + Latanoprost ophthalmic solution (NCT02466399)
- 2020-10-23Results posted on the registry: Santen Inc., Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution + Topical ultra-low dose of DE-126 Ophthalmic Solution (NCT03216902)
- 2020-08-27Results posted on the registry: Bausch & Lomb Incorporated, PF-03187207 + Latanoprost 0.005% (NCT00595101)
- 2020-08-27Results posted on the registry: Bausch & Lomb Incorporated, PF-03187207 and Latanoprost Vehicle + Latanoprost 0.005% and PF-03187207 Vehicle (NCT00441883)
- 2020-07-31Also stopped (withdrawn): Jonsson Comprehensive Cancer Center, bimatoprost ophthalmic solution + placebo (NCT00999557)
- 2020-07-02Phase 3 first posted: Alexandria University, Preservative-free tafluprost eye drops (NCT04455126)
- 2020-06-24Phase 3 first posted: Nicox Ophthalmics, Inc., NCX 470 0.065% (initial phase of trial) + Latanoprost 0.005% (initial phase of trial) (NCT04445519)
- 2020-06-04Results posted on the registry: ForSight Vision5, Inc., Bimatoprost + Timolol 0.5% (NCT02358369)
- 2020-04-24Results posted on the registry: Allergan, Bimatoprost SR + Active Comparator: Timolol 0.5% (NCT02247804)
- 2020-04-02Results posted on the registry: Laboratoires Thea, Monoprost + Lumigan 0.01% (NCT02017327)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision